| 2023 | Discovery of New Anti-Cancer Agents against Patient-Derived Sorafenib-Resistant Papillary Thyroid Cancer
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2023 | Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer | CANCER GENE THERAPY |
| 2023 | Anti-Cancer SERCA Inhibitors Targeting Sorafenib-Resistant Human Papillary Thyroid Carcinoma
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2023 | PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models
| BMC MEDICINE |
| 2022 | Potential Therapeutic Agents against Paclitaxel-And Sorafenib-Resistant Papillary Thyroid Carcinoma
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2022 | Discovery of Pharmaceutical Composition for Prevention and Treatment in Patient-Derived Metastatic Medullary Thyroid Carcinoma Model
| BIOMEDICINES |
| 2022 | Drug Discovery Using Evolutionary Similarities in Chemical Binding to Inhibit Patient-Derived Hepatocellular Carcinoma
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2022 | Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2021 | Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2020 | Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
| 2020 | Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice
| INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY |
| 2020 | Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer
| CANCERS |
| 2019 | VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis
| BMC Cancer |
| 2019 | Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer
| Translational Oncology |
| 2018 | Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype
| Nature Communications |
| 2018 | SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with altnernating Sorafenib and Lenvatinib for refractory thyroid cancer
| BMC CANCER |
| 2018 | Protective effects of guggulsterone against colitis are associated with the suppression of TREM-1 and modulation of macrophages | AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY |
| 2018 | Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells
| NEOPLASIA |
| 2018 | Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2α-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase Expression | CLINICAL CANCER RESEARCH |
| 2017 | Synergistic Activity of N-hydroxy-7-(2-naphthylthio) Heptanomide and Sorafenib Against Cancer Stem Cells, Anaplastic Thyroid Cancer
| NEOPLASIA |
| 2015 | Potential anti-cancer effect of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a novel histone deacetylase inhibitor, for the treatment of thyroid cancer.
| BMC CANCER |
| 2015 | Inhibition of endoplasmic reticulum chaperone protein glucose-regulated protein 78 potentiates anti-angiogenic therapy in renal cell carcinoma through inactivation of the PERK/eIF2α pathway
| ONCOTARGET |
| 2015 | The bifunctional autophagic flux by 2-deoxyglucose to control survival or growth of prostate cancer cells
| BMC CANCER |
| 2015 | The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells
| BMC CANCER |
| 2014 | A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells
| BRITISH JOURNAL OF PHARMACOLOGY |
| 2013 | Effects of endostatin and a new drug terpestacin against human neuroblastoma xenograft and cell lines | PEDIATRIC SURGERY INTERNATIONAL |
| 2013 | Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer | CELLULAR ONCOLOGY |
| 2011 | Potential anti-cancer activity of N-hydroxy-7-(2-naphthylthio) heptanomide (HNHA), a histone deacetylase inhibitor, against breast cancer both in vitro and in vivo | CANCER SCIENCE |
| 2010 | Terpestacin inhibits tumor angiogenesis by targeting UQCRB of mitochondrial complex III and suppressing hypoxia-induced reactive oxygen species production and cellular oxygen sensing
| JOURNAL OF BIOLOGICAL CHEMISTRY |
| 2008 | Effect of selective cyclooxygenase-2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ducts | HEPATOLOGY RESEARCH |
| 2006 | Accumulation of β-catenin protein, mutations in exon-3 of the β-catenin gene and a loss of heterozygosity of 5q22 in solid pseudopapillary tumor of the pancreas | JOURNAL OF SURGICAL ONCOLOGY |
http://orcid.org/0000-0002-3435-3985
